![Pieter Jaap Gaillard](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pieter Jaap Gaillard
Gründer bei Mireca Medicines GmbH
Aktive Positionen von Pieter Jaap Gaillard
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Mireca Medicines GmbH
![]() Mireca Medicines GmbH Pharmaceuticals: MajorHealth Technology Mireca Medicines GmbH develops treatment for hereditary eye disease. The company was founded by François Paquet-Durand, Pieter Jaap Gaillard and Barbara Brunnhuber in 2017 and is headquartered in Tubingen, | Vorsitzender | 01.04.2017 | - |
Gründer | 01.01.2017 | - |
Karriereverlauf von Pieter Jaap Gaillard
Ehemalige bekannte Positionen von Pieter Jaap Gaillard
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
to-BBB technologies BV
![]() to-BBB technologies BV Pharmaceuticals: MajorHealth Technology BBB Therapeutics BV develops medicines for brain disease treatment. The firm uses its platform technology to enhance the delivery of established and marketed drugs over the blood brain-barrier. It offers its patented central nervous system (CNS) drug targeting technology to their partners in pharmaceutical and biotechnology industry. The firm's products include 2B3-101 and 2B3-201. The company was founded by Pieter Jaap Gaillard, Bert de Boer, and Alfred N. Nijkerk in 2003 and is headquartered in Leiden, the Netherlands. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2003 | - |
Gründer | 01.01.2003 | - |
Ausbildung von Pieter Jaap Gaillard
University of Leiden | Doctorate Degree |
University of Utrecht | Graduate Degree |
Statistik
International
Niederlande | 4 |
Deutschland | 2 |
Operativ
Founder | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Graduate Degree | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
to-BBB technologies BV
![]() to-BBB technologies BV Pharmaceuticals: MajorHealth Technology BBB Therapeutics BV develops medicines for brain disease treatment. The firm uses its platform technology to enhance the delivery of established and marketed drugs over the blood brain-barrier. It offers its patented central nervous system (CNS) drug targeting technology to their partners in pharmaceutical and biotechnology industry. The firm's products include 2B3-101 and 2B3-201. The company was founded by Pieter Jaap Gaillard, Bert de Boer, and Alfred N. Nijkerk in 2003 and is headquartered in Leiden, the Netherlands. | Health Technology |
Mireca Medicines GmbH
![]() Mireca Medicines GmbH Pharmaceuticals: MajorHealth Technology Mireca Medicines GmbH develops treatment for hereditary eye disease. The company was founded by François Paquet-Durand, Pieter Jaap Gaillard and Barbara Brunnhuber in 2017 and is headquartered in Tubingen, | Health Technology |
- Börse
- Insiders
- Pieter Jaap Gaillard
- Erfahrung